P/E ratio for Zepp Health (ZEPP)
P/E ratio as of May 2024 (TTM): -1.22
According to Zepp Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.2197. At the end of 2022 the company had a P/E ratio of -2.05.
P/E ratio history for Zepp Health from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -2.05 | -113.9% |
| 2021 | 14.7 | -31.8% |
| 2020 | 21.6 | 141.92% |
| 2019 | 8.92 | -103.68% |
| 2018 | -243 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Qorvo
QRVO | -101 | 8,143.09% | 🇺🇸 USA |
 QUALCOMM QCOM | 30.1 | -2,566.08% | 🇺🇸 USA |
 EchoStar SATS | 13.0 | -1,167.67% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.